Inadequate safety reporting in the publications of randomised clinical trials in irritable bowel syndrome: drug versus probiotic interventions
A.M. van der Geest Related information1Vrije Universiteit Amsterdam, Athena Institute, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands.
*Corresponding author:
a.m.vander.geest@vu.nl,
I. Schukking Related information1Vrije Universiteit Amsterdam, Athena Institute, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands.
,
R.J.M. Brummer Related information2Nutrition-Gut-Brain Interactions Research Centre, School of Medical Sciences, Faculty of Medical and Health Sciences, Örebro University, Fakultetsgatan 1, 70182 Örebro, Sweden.
,
H. Pieterse Related information3University of Ghent, Heymans Institute of Pharmacology, C. Heymanslaan 10, 9000 Ghent, Belgium.
,
M. van den Nieuwboer Related information4Stichting Darmgezondheid, Oversteek 35, 6717 ZS Ede, the Netherlands.
,
L.H.M. van de Burgwal Related information1Vrije Universiteit Amsterdam, Athena Institute, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands.
,
O.F.A. Larsen Related information1Vrije Universiteit Amsterdam, Athena Institute, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands.
留言 (0)